STERIS Corp. Director Sells $274,487 in Stock (STE)
STERIS Corp. (NYSE:STE) Director Michael B. Wood sold 5,300 shares of STERIS Corp. stock on the open market in a transaction dated Monday, August 11th. The shares were sold at an average price of $51.79, for a total transaction of $274,487.00. Following the sale, the director now directly owns 22,855 shares of the company’s stock, valued at approximately $1,183,660. The transaction was disclosed in a document filed with the SEC, which is available at this link.
STERIS Corp. (NYSE:STE) traded up 1.31% during mid-day trading on Tuesday, hitting $52.41. 360,158 shares of the company’s stock traded hands. STERIS Corp. has a 52-week low of $39.90 and a 52-week high of $55.36. The stock has a 50-day moving average of $52.95 and a 200-day moving average of $50.04. The company has a market cap of $3.110 billion and a P/E ratio of 25.36.
STERIS Corp. (NYSE:STE) last released its earnings data on Tuesday, August 5th. The company reported $0.54 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.54. The company had revenue of $412.60 million for the quarter, compared to the consensus estimate of $418.26 million. During the same quarter last year, the company posted $0.44 earnings per share. STERIS Corp.’s revenue was up 12.2% compared to the same quarter last year. Analysts expect that STERIS Corp. will post $2.86 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Tuesday, September 23rd. Shareholders of record on Tuesday, August 26th will be paid a dividend of $0.23 per share. This represents a $0.92 annualized dividend and a dividend yield of 1.78%. The ex-dividend date of this dividend is Friday, August 22nd. This is a positive change from STERIS Corp.’s previous quarterly dividend of $0.21.
STERIS Corporation (NYSE:STE) is a provider of infection prevention and surgical products and services, focused on healthcare, pharmaceutical and research.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.